Oliver Viehmann

Oliver Viehmann, Principal at TWS Partners, discusses game theory in the pharmaceutical industry. They explore drug pricing mechanisms, including regulatory cost-effectiveness and competitive procurement. The complexities and challenges of volume-based procurement in China are examined, highlighting the game theoretic dynamics between payers and manufacturers. Explore different pricing approaches, including outcome-based pricing.